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Abstract
Background: A healthy dietary pattern defined by international recommendations of the World Health Organisation (WHO)
has been shown to reduce overall mortality risk. It is unknown whether this healthy dietary pattern is associated with overall
cancer incidence.
Design: In total 35,355 men and women within the Dutch European Prospective Investigation into Cancer and Nutrition-
cohort were followed for cancer occurrence. Diet was assessed through a validated food-frequency questionnaire. We
computed a dietary score for all participants based on the seven WHO dietary guidelines for the prevention of chronic
diseases (Healthy Diet Indicator (HDI)). We used the existing HDI score based on the 1990 WHO guidelines, and adapted it to
meet with the 2002 WHO guidelines. Multivariate-adjusted Cox proportional hazards analysis was used to examine the
association between adherence to the HDI and subsequent overall cancer risk.
Results: A number of 3,007 new cancers were identified during a mean follow-up of 12.7 years. Adherence to the HDI was
not associated with a reduced overall cancer risk. The hazard ratio (HR) of overall cancer associated with a one-point
increment of the HDI was 0.96 (95% CI 0.89–1.03) in men, and 1.00 (95% CI 0.96–1.04) in women. Adherence to the HDI was
not associated with smoking-related cancer ((HR men: 0.94 (95% CI 0.84–1.04); HR women: 1.00 (95% CI 0.94–1.07)), or
alcohol-related cancer ((HR men: 1.02 (95% CI 0.87–1.20); HR women: 1.03 (95% CI 0.98–1.08)).
Conclusions: Greater adherence to the WHO’s Healthy Diet Indicator, a dietary pattern for prevention of chronic diseases,
was not associated with reduced overall, smoking-related or alcohol-related cancer risk in men or women.
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Introduction
The Netherlands has the 12th highest cancer rates in the world.
Every year 286.8 people out of every 100,000 develop cancer [1]
and the disease accounts for nearly one third of total annual
mortality in the Netherlands [2]. Dietary habits are recognized to
be important modifiable factors influencing cancer risk [3,4] and
have been estimated, together with overweight/obesity and
physical activity, to account for approximately 35–38% of 12
common cancers in high-income countries, according to the
World Cancer Research Fund/American Institute for Cancer
Research (WCRF/AICR) [5]. Dietary patterns examine effects of
overall diet and allow for underlying synergistic effects between the
individual dietary components [6]. Most of the studies that relate
dietary patterns to health outcomes use either a priori (researcher-
driven) diet scores, or a posteriori (data-driven) scores derived from
factor- or cluster analysis. A priori dietary scores can be further
grouped into three categories; (a) scores that assess dietary variety
or diversity, (b) scores that assess concordance with dietary
guidelines and (c) scores that assess specific dietary patterns (e.g.
the Mediterranean diet) [7]. The Mediterranean dietary pattern
has been found to reduce risk for cancer morbidity and mortality
for some countries (especially the Mediterranean countries), but
not for other, more Northern countries such as the Netherlands
[8,9].
In 1990, the World Health Organisation (WHO) published
international dietary guidelines for prevention of chronic diseases.
Successively, the Healthy Diet Indicator (HDI) was developed by
Huijbregts et al. [10] to quantify adherence to these guidelines.
Previous studies have related the HDI to overall- and cancer-
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specific mortality. The HDI was found to be inversely related to
all-cause mortality in elderly men of three European countries (RR
for high versus low HDI adherence: 0.87, 95% CI: 0.77–0.98)
[10]. This study also found risk of death from cardiovascular
disease and cancer to be respectively 18% and 15% lower in the
highest HDI group than in the lowest group, but specific estimates
were not provided. In another cohort of elderly European men
and women, a higher HDI was related to lower all-cause mortality
(HR: 0.89 with 95% CI: 0.81–0.98), however, cancer mortality
was not investigated [11]. In addition, the HDI was studied in
relation to breast cancer risk in British women; however, no
association was found (HR for maximal adherence to the HDI
compared with minimal adherence: 0.94 with 95% CI: 0.67–1.32)
[12].
As far as we know, no prospective study has related adherence
to this dietary pattern to the occurrence of overall cancer. We
aimed to investigate the association between adherence to the HDI
and risk of overall cancer incidence, as well as alcohol- and
smoking-related cancer. We examined associations separately for
men and women participating in the Dutch part of the European
Prospective Investigation into Cancer and Nutrition (EPIC-NL)
cohort study.
Subjects and Methods
Study Population
The EPIC-NL study consists of the two Dutch contributions to
the EPIC cohort: Prospect and MORGEN cohorts [13]. The
study design has been described elsewhere [14]. In brief, Prospect
is a prospective cohort study of 17,357 women, aged 49–70, who
participated in breast cancer screening between 1993 and 1997
[15]. The MORGEN cohort consists of 22,654 men and women
aged 20–65 years recruited from three Dutch cities (Amsterdam,
Doetinchem, and Maastricht) between 1993 and 1997 [16]. In
total, there were 40,011 participants in the EPIC-NL cohort. All
participants provided written informed consent before study
inclusion. The study complies with the Declaration of Helsinki
and was approved by the institutional board of the University
Medical Center Utrecht (Prospect) and the Medical Ethical
Committee of TNO Nutrition and Food Research (MORGEN).
The present analysis was restricted to participants with no prior
history of cancer and with complete dietary data. Initially, 40,011
participants were available out of which 39,793 participants had
complete dietary data. Participants with prevalent cancer or with
missing data regarding history of cancer (n = 1688) were excluded.
Participants who gave no permission for linkage with vital status
registries were excluded (n= 2028), as well as participants without
follow-up data (n = 391). Participants who reported unlikely energy
intakes (n = 331) were excluded (those in the top 0.5% and bottom
0.5% of the ratio of self-reported energy intake to basal metabolic
rate). In total, 35,355 participants were included in the final study
population (9,188 men and 26,167 women). The analyses were
restricted to first incident cancers.
Healthy Diet Indicator
To quantify adherence to the WHO’s guidelines for prevention
of chronic diseases we used the Healthy Diet Indicator, which
incorporated 7 WHO recommendations regarding nutrients or
food groups [17]. Daily dietary intake was obtained at recruitment
from a food-frequency questionnaire (FFQ) containing questions
on the usual frequency of consumption of 79 main foods during
the year preceding recruitment. This questionnaire allows the
estimation of the average daily consumption of 178 foods. The
FFQ has been validated against twelve 24-h recalls, administered
once a month for one year [18,19]. Pearson correlation coefficients
were 0.61 (men) and 0.63 (women) for fat, 0.71 (men) and 0.67
(women) for protein, 0.74 (men) and 0.76 (women) for carbohy-
drate, and 0.61 (men) and 0.74 (women) for fibre. Macro- and
micronutrients values of reported foods (expressed per 100 grams
edible portion) were obtained from national tables compiled by the
Dutch Food Composition Database (NEVO). The HDI was
originally created by Huijbregts et al. according to WHO
recommendations of 1990 [10]. The WHO provided updated
guidelines in 2002 and we adapted the HDI accordingly [20].
Detailed information on the operationalization of the HDI is
shown in Table 1. Seven food groups and nutrients were included
in the updated HDI: saturated fatty acids; polyunsaturated fatty
acids; cholesterol; protein; dietary fibre; fruits and vegetables; and
free sugars. In concordance with the updated WHO guidelines,
three former HDI components were omitted in the updated HDI:
‘monosaccharides and disaccharides’, ‘complex carbohydrates’
and ‘pulses, nuts and seeds’. Also, the component ‘free sugars’
(including monosaccharides, disaccharides, and sugars from
honey, syrups and fruit juices) was added to the updated HDI.
We excluded the component salt from the HDI because we did not
have valid information: previously Huijbregts et al. also excluded
this recommendation since only sodium content in foods was
available but it was unknown how much salt was added during
preparation of meals and at the table.
A dichotomous variable was generated for each component of
the HDI. If a person’s intake was within the recommended range
according to WHO’s guidelines this variable was coded as 1;
otherwise it was coded as 0. The HDI was the sum of all these
dichotomous variables and had a range of 0–7 points.
Ascertainment of Cancer Events
During follow-up, participants were followed for disease
occurrence and cancer cases were identified by annual linkage
to the Netherlands Cancer Registry. This registry identifies
incident cancer cases through pathology records and is 95%
complete since 1989. Follow-up for cancer incidence and vital
status was complete until December 31, 2008. Prevalent cases of
cancer were also identified through linkage with the cancer
registry and by self-report using the baseline general questionnaire
[14]. Smoking-related cancer was defined as cancer of the lung,
kidney, upper aero-digestive tract, liver, stomach, pancreas,
bladder and colorectum [21,22]. Alcohol-related cancer included
cancer of the upper aero-digestive tract, breast, liver, and
colorectum [23].
Covariates
At baseline, participants completed a lifestyle questionnaire
including questions on demographics, presence of chronic diseases,
and risk factors for chronic diseases. Participants returned the
questionnaire when coming for a physical examination, and
completeness of the questionnaire was discussed. During the
physical examination height and weight were measured, and body
mass index (BMI; kg/m2), was calculated. Physical activity was
assessed using the EPIC physical activity questionnaire [24] and
categorized according to the validated Cambridge Physical
Activity Index (inactive, moderately inactive, moderately active,
active) [25,26]. Because data on physical activity was not available
for 14% of the EPIC-NL cohort, these missing values were
imputed using single linear regression modelling [27]. Smoking
status was categorized as never, former, current smoking, and
current smokers were further categorized into categories of
average number (1, 2–10, 10–20, .20) of cigarettes per day.
Education was categorized as low (primary to completing
WHO’s Healthy Diet Indicator and Overall Cancer
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intermediate vocational education) intermediate (high secondary
education), and high (high vocational education or university).
Statistical Analysis
Simple tabulations were made for sociodemographic data by sex
and by tertiles of the HDI. Multivariate Cox proportional hazards
regression models were fitted to estimate cancer hazard ratios
(HRs) and corresponding 95% confidence intervals (CIs). The time
variable was the interval between date of recruitment to date of
cancer diagnosis or censoring (death, lost to follow-up or end of
follow-up (December 2008)), whichever occurred first.
HRs were calculated for overall cancer, smoking-related cancer
and alcohol-related cancer. Results were computed for men and
women separately because of differences in cancer types and
confounders. All models were stratified by cohort (Morgen or
Prospect).
The HDI was analysed as a continuous variable (per 1-unit
increase of the HDI) and in three groups of approximately equal
numbers (HDI= 0–2, 3, and 4–7) with the first tertile (least healthy
HDI) as the reference category. P-values for linear trend across the
tertiles were calculated by including the categorical HDI as a
continuous variable in the model.
Multivariate analyses were adjusted for age at baseline (years),
BMI, smoking status, total energy intake excluding energy from
alcohol (kcal/day), alcohol intake (g/day), physical activity level
and educational level. Analyses in women were additionally
adjusted for menopausal status (pre-, peri-, and postmenopausal;
surgical menopause; or missing). Parity, breastfeeding, hormone-
replacement therapy, and marital status were not included in the
model since these variables were not confounders in the
association between HDI and overall or alcohol-related cancer.
Possible modifying effects of sex, BMI and smoking status were
investigated by adding interaction terms (with the continuous HDI
variable) to the statistical model.
We estimated the individual association of each component of
the HDI with overall cancer risk, adjusting for all six other
components of the score and for the covariates mentioned
before.To examine whether associations would be different for
participants who developed cancer early or late during follow-up
relative to the baseline dietary measurement we repeated the main
analysis in follow-up periods of ,5 years, 5–10 years and .10
years.
Additionally, we computed models excluding participants with
less than two years of follow-up to prevent that dietary habits had
changed in response to early symptoms of the yet undiagnosed
cancer. We also investigated whether associations were different
for the updated HDI (according to WHO 2002 guidelines) as
compared to the former HDI used by Huijbregts et al. (according
to 1990 WHO guidelines). For that aim we repeated the main
analysis of overall cancer using Huijbregts’ compilation of the HDI
[10]. All analyses were performed using SAS, version 9.2 (SAS
Institute, Cary, NC).
Results
During 12.7 years of follow-up, 586 men and 2,421 women
were diagnosed with cancer. Due to the population selection for
EPIC-NL, mean age at baseline in tertiles of the HDI varied
between 42 and 44 years for men and between 51 and 52 years for
women (Table 2). The percentage current smokers ranged from
28–40% in men; and from 22–30% in women between HDI
tertiles, while alcohol intake ranged from 16–20 g/day in men;
and from 8–9 g/day in women between HDI tertiles. A higher
adherence to the HDI was observed in participants with higher
education level, higher physical activity levels and among never
and former smokers. Men and women with high adherence to the
HDI also had a lower BMI and lower use of alcohol, compared
with participants with low adherence to the HDI.
Adherence to the HDI was not significantly associated with a
reduction in overall cancer risk (Table 3). The hazard ratio (HR) of
overall cancer associated with a 1-point increment of the HDI was
0.99 (95% CI 0.96–1.02) for the total cohort; 0.96 (95% CI 0.89–
1.03) for men; and 1.00 (95% CI 0.96–1.04) for women. Tertile-
specific HRs for men were 1.12 (95% CI 0.91–1.37) and 0.93
(95% CI 0.75–1.15), for a HDI of 3 (tertile 2) and 4–7 (tertile 3)
compared with 0–3 (tertile 1) (P for linear trend= .46). For women,
HRs were 0.93 (95% CI 0.84–1.03) for the second, and 0.98 (95%
CI 0.88–1.08) for the third tertile of adherence to thze HDI (P for
linear trend= .67).
Adherence to the HDI was not significantly associated with risk
of smoking-related and alcohol-related cancer (Table 3). For
smoking-related cancers, the HR per 1-point increment of the
HDI was 0.94 (95% CI 0.84–1.04) for men and 1.00 (95% CI
0.94–1.07) for women. For alcohol-related cancers, the HR per 1-
point increment of the HDI was 1.02 (95% CI 0.87–1.20) for men
and 1.03 (95% CI 0.98–1.08) for women.
Table 1. Composition of the Healthy Diet Indicator1 (HDI) used in analyses of cancer, based on the WHO’s dietary guidelines for
the prevention of chronic diseases.
Scoring criteria
Nutrient or food group (daily intake) Criteria for 1 point Criteria for 0 points
Saturated fatty acids (en%)2 ,10 $10
Polyunsaturated fatty acids (en%)2 6–10 ,6 or .10
Cholesterol (mg) ,300 $300
Protein (en%)2 10–15 ,10 or .15
Dietary fibre (g) .25 #25
Fruits and vegetables (excluding potatoes) (g) $400 ,400
Free sugars (en%)2 ,10 $10
1HDI range was 0–7 points. Tertiles of adherence to the HDI was; T1: ,3 points, T2:3 points, T3: .3 points.
2(en%) refers to the percentage of total energy intake excluding alcohol.
Abbreviations: mg, milligrams, g, grams, en%, energy percentage.
doi:10.1371/journal.pone.0070535.t001
WHO’s Healthy Diet Indicator and Overall Cancer
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No statistically significant interaction was found between the
HDI and sex (P for interaction= .22), BMI (P= .83), or smoking
status (P= .89) on overall cancer (results not shown).
When examining possible associations between the seven
components of the HDI and overall cancer risk (Table 4), we
found a borderline statistically significant increase in cancer risk
with saturated fat intake. The HR for overall cancer associated
with an increment in daily saturated fat intake of 3 percent of total
energy intake was 1.06 (95% CI 1.00–1.11). No statistically
significant associations were observed for the other components.
Associations for overall cancer were comparable for all follow-up
periods. For cancers occurring within 5 years the HR for overall
cancer per one-point increment of the HDI was 0.99 (95% CI
0.93–1.06) (men and women combined); for cancers occurring
within 5–10 years the HR was 1.02 (95% CI 0.97–1.08); for
cancers occurring .10 years the HR was 1.00 (95% CI 0.95–
1.06).
To address potential residual confounding by tobacco smoking,
we repeated the main analysis in never smokers and found results
comparable to results in the total population after adjusting for
smoking (HR of overall cancer associated with a one-point
increment of the HDI was 0.99 (95% CI 0.94–1.05)).
Excluding cancers occurring within two years of follow-up did
not alter the association with overall cancer (data not shown). Re-
analysing the data replacing the current HDI with the HDI based
on the 1990 WHO guidelines resulted in risk estimates of the same
order of magnitude [10].
Discussion
This study shows that higher adherence to the WHO’s Healthy
Diet Indicator, a dietary pattern for prevention of chronic diseases,
was not associated with overall, smoking- or alcohol-related
cancer. Each point increment of the HDI reduced risk in men by
4%, but this was statistically not significant, while the association
was null in women. In additional sensitivity analyses, estimates for
overall cancer risk proved relatively robust.
Two previous studies [10,11] related the HDI, based on the
WHO guidelines of 1990, to overall mortality but not cancer risk;
therefore we could not directly compare results. Both studies did
find inverse associations with overall-mortality in different pooled
populations. Huijbregts et al. found a reduction in overall
Table 2. Baseline characteristics and number of incident cancers in the EPIC-NL cohort according to tertiles of adherence to the
Healthy Diet Indicator (HDI).
Adherence to HDI1
Men (n=9188) Women (n=26167)
Baseline characteristic All participants Tertile 12 Tertile 22 Tertile 32 Tertile 12 Tertile 22 Tertile 32
N (%) 35355 (100.0) 2433 (26.5) 3173 (34.5) 3582 (39.0) 6917 (26.4) 9577 (36.6) 9673 (37.0)
Age (years; mean, s.d.) 49.2 (11.9) 44.1 (11.0) 43.6 (11.0) 42.4 (11.1) 52.0 (11.3) 51.2 (11.3) 50.8 (11.8)
Body Mass Index (kg/m2; mean, s.d.) 25.7 (4.0) 26.1 (3.6) 25.9 (3.5) 25.5 (3.5) 25.8 (4.2) 25.7 (4.2) 25.5 (4.1)
Energy intake (kcal/day; mean, s.d.) 1977 (590) 2357 (652) 2427 (693) 2556 (601) 1733 (449) 1745 (444) 1925 (460)
Alcohol intake (g/day; mean, s.d.) 11.0 (15.3) 20.3 (23.6) 18.5 (20.1) 15.9 (17.9) 8.7 (12.6) 9.2 (12.7) 7.8 (11.2)
Smoking status (N, %)
Never 13508 (39.2) 653 (27.7) 915 (29.8) 1224 (35.7) 2796 (41.1) 3745 (40.0) 4175 (44.1)
Former 11293 (32.7) 765 (32.5) 1087 (35.5) 1248 (36.4) 1995 (29.3) 2978 (31.8) 3220 (34.0)
Current 9687 (28.1) 939 (39.8) 1064 (34.7) 960 (28.0) 2016 (29.6) 2637 (28.2) 2071 (21.9)
Education (N, %)
Low 24440 (69.5) 1606 (66.3) 1959 (62.0) 22120 (59.3) 5226 (76.1) 6921 (72.7) 6608 (68.7)
Middle 3533 (10.0) 274 (10.9) 341 (10.8) 373 (10.4) 649 (9.5) 932 (9.8) 974 (10.1)
High 7200 (20.5) 551 (22.8) 862 (27.3) 1085 (30.3) 989 (14.4) 1674 (17.6) 2039 (21.2)
Physical activity (N, %)
Inactive 3208 (9.1) 396 (16.3) 396 (12.5) 313 (8.7) 699 (10.1) 741 (7.7) 663 (6.9)
Moderately inactive 10184 (28.8) 783 (32.2) 996 (31.4) 1033 (28.8) 2019 (29.2) 2841 (29.7) 2512 (26.0)
Moderately active 9815 (27.8) 646 (26.6) 912 (28.7) 1077 (30.1) 1869 (27.0) 2657 (27.7) 2654 (27.4)
Active 12148 (34.4) 608 (25.0) 869 (27.4) 1159 (32.4) 2330 (33.7) 3338 (34.9) 3844 (39.7)
Menopausal status (N, %)
Premenopausal 8273 (31.6) – – – 2004 (29.0) 3048 (31.8) 3221 (33.3)
Postmenopausal 12441 (47.5) – – – 3425 (49.5) 4472 (46.7) 4544 (47.0)
Cancer cases (N, %)
Overall cancer 3007 (8.5) 167 (6.9) 225 (7.1) 194 (5.4) 688 (10.0) 864 (9.0) 869 (9.0)
Smoking-related cancer 1032 (3.1) 93 (3.9) 98 (3.2) 89 (2.6) 209 (3.2) 290 (3.2) 253 (2.8)
Alcohol-related cancer 1413 (4.2) 37 (1.6) 45 (1.5) 45 (1.3) 346 (5.3) 459 (5.0) 481 (5.2)
1HDI (range 0–7 points) included 7 components: saturated fatty acids, polyunsaturated fatty acids, cholesterol, protein, fibre, fruits and vegetables and free sugars.
2HDI tertiles: T1: ,3 points; T2:3 points; T3: .3 points.
doi:10.1371/journal.pone.0070535.t002
WHO’s Healthy Diet Indicator and Overall Cancer
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mortality of 13% for people with highest versus lowest tertile of
HDI (95% CI: 2–23%) [10]. The reported estimate for the
Netherlands was 25%, but not statistically significant, possibly due
to lack of power. The difference in associations could be due to the
population selection: Huijbregts et al studied only elderly men,
while we also found lower risk estimates in men. However our
power in males was limited due to low numbers of male cases (586
versus 1796 in Huijbregts’ study). In addition, men in our study
were quite young at the end of follow up, and dietary patterns at
older ages may differ. In the study of Knoops et al., estimates for
individual countries were not provided, however the estimate for
Northern Europe was comparable with our estimate (HR: 0.93;
95% CI: 0.85–1.02) [11]. In addition, another study found no
reduction of risk of breast cancer for a higher HDI in British
women (HR for maximal adherence to the HDI compared with
minimal adherence: 0.94 with 95% CI: 0.67–1.32) [12].
Although the HDI has been associated with reduced all-cause
mortality and reduced mortality from cardiovascular diseases, in
our study this indicator was not related to cancer risk. Our results
are consistent with other studies, showing that scores that include
beneficial dietary components, but not other lifestyle factors such
as overweight and smoking, are only weakly related to cancer risk
if related at all [28–33]. It may be that dietary scores aiming for
general prevention of chronic diseases, are more strongly
associated with cardiovascular disease than with cancer because
of the specific dietary components included [34]. For example, red
meat and dairy products were not included in the HDI, whereas
red meat is an established risk factor for colon cancer, and milk has
been shown to be protective for this type of cancer [35–39]. There
is also debate on whether dietary scores should incorporate a
weight loss component, since excess body weight is directly
associated with risk of cancer [40]. Although we adjusted our
Table 3. Multivariable hazards ratios (HRs) and 95% CIs of cancer according to tertiles of adherence to the Healthy Diet Indicator
(HDI) in the EPIC-NL cohort.
HR (95% CI)1
Group of cancers Tertile 1 Tertile 2 Tertile 3
Continuous (per 1-point
increment) P for trend5
Overall cancer
All participants 1 (referent) 0.97 (0.89–1.06) 0.97 (0.88–1.06) 0.99 (0.96–1.02) .53
Men 1 (referent) 1.12 (0.91–1.37) 0.93 (0.75–1.15) 0.96 (0.89–1.03) .46
Women2 1 (referent) 0.93 (0.84–1.03) 0.98 (0.88–1.08) 1.00 (0.96–1.04) .67
Smoking-related cancer3
Men 1 (referent) 0.90 (0.68–1.20) 0.83 (0.62–1.12) 0.94 (0.84–1.04) .23
Women2 1 (referent) 1.07 (0.90–1.28) 1.03 (0.85–1.24) 1.00 (0.94–1.07) .78
Alcohol-related cancer4
Men 1 (referent) 1.00 (0.64–1.54) 0.97 (0.62–1.52) 1.02 (0.87–1.20) .90
Women2 1 (referent) 0.97 (0.84–1.11) 1.05 (0.91–1.21) 1.03 (0.98–1.08) .46
1All models were stratified by sex and cohort, and adjusted for age at baseline, body mass index, smoking status, education, physical activity, energy intake without
energy from alcohol, and alcohol intake.
2Models in women were additionally adjusted for menopausal status.
3Smoking-related cancer included cancer of the lung, kidney, upper aero-digestive tract, stomach, pancreas, bladder, liver, and colorectal.
4Alcohol-related cancer included cancer of the upper aero-digestive tract, breast, liver, and colorectal.
5P for trend values were calculated using two-sided test for linear trend, treating the HDI categories as a continuous variable.
doi:10.1371/journal.pone.0070535.t003
Table 4. HR and 95% CI for overall cancer associated with increments in the components of the Healthy Diet Indicator (men and
women combined).
HDI component Mean (s.d.) consumption Increment1 HR (95% CI)2
Saturated fatty acids (en%/day)3 14.6 (2.6) 3 1.06 (1.00–1.11)
Polyunsaturated fatty acids (en%/day)3 6.7 (1.8) 2 1.00 (0.97–1.05)
Cholesterol (mg/day) 225.4 (85.6) 86 1.00 (0.94–1.07)
Protein (en%/day)3 16.1 (2.4) 2 1.00 (0.97–1.05)
Dietary fibre (g/day) 23.8 (6.6) 7 1.01 (0.94–1.09)
Fruits and vegetables (g/day) 308.0 (155.6) 156 1.02 (0.97–1.07)
Free sugars (en%/day)3 6.6 (4.3) 4 1.03 (0.98–1.08)
1The increment is a rounded number close to the s.d. of the component.
2All models were stratified cohort, and adjusted for sex, age at baseline, body mass index, smoking status, education, physical activity, energy intake without energy
from alcohol, and alcohol intake.
3(en%) refers to the percentage of total energy intake excluding alcohol.
Abbreviations: s.d., standard deviation, m, milligrams, g, grams, en%, energy percentage, HR, hazard ratio, CI, confidence interval.
doi:10.1371/journal.pone.0070535.t004
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analyses for body mass index, it is possible that this did not
completely account for the influence of body fatness. This is
supported by two recent studies, showing that a diet-lifestyle score,
including the component body fatness, was significantly associated
with cancer risk [41,42].
An alternative explanation for our null results is that for some
dietary components, the range of intake from low to high HDI
adherence in our study population was relatively modest, which
could be an indication for small between-person variance in diet in
relation to within-person variance. Furthermore, all seven
components, and related foods have been equally weighted in
the computation of the HDI although their associations with
cancer may differ. Creating a priori dietary scores like the HDI
requires researchers to make arbitrary decisions concerning the
foods or nutrients to be included, their scoring, and the cut-off
values to be used [6]. A posteriori methods could overcome these
issues by grouping participants according to their dietary
characteristics and similarity.
Advantages of the present study are the prospective design, the
long follow-up period and complete ascertainment of cancers, the
large sample size specific for women and the inclusion of a number
of potential important confounders. In addition to overall cancer,
we studied cancer sites specifically related to alcohol and smoking.
We adjusted for study cohort (i.e. Prospect or Morgen) to adjust
for differences in study population.
There were several limitations to this study. Although the FFQ
used in this study had been validated, results could have been
affected by measurement error in dietary intake. Particularly for
fat and protein intake, correlations with intakes obtained through
24-h recalls were modest (fat; men: 0.61; women: 0.63 and protein;
men: 0.71; women: 0.67) [18,19]. Moreover, correlations for
saturated fat, poly-unsaturated fatty acids, or cholesterol (all used
for construction of the HDI) were not available from the validation
study. A potential limitation may be that cases could have
modified their diet during the early pre-diagnostic period;
however, excluding incident cases diagnosed in the first 2 years
of follow-up did not alter associations. Underreporting by
participants with high energy or fat intakes could also have played
a role; especially in women since they are more likely than men to
underreport their intake [43].
Physical activity was missing for 14% of the EPIC-NL cohort.
Simply excluding these participants would have provided biased
results, since missing data did not occur completely at random and
this may have resulted in misclassification of physical activity for
the concerned participants [44]. We therefore imputed these
missing values using single imputation. Women in Prospect
(approximately 59% of our female study population) were
participating in a screening trial, and this could be associated
with healthier (dietary) behaviours. This may limit generalizability
of our results to women exposing more unhealthy behaviour.
However, still a major part of our study population (women and
men within the MORGEN cohort) was reflecting the general
Dutch population. More importantly, the fact that women within
our study may have been altogether slightly more healthy does not
affect the internal validity of our study. Prevalence estimates of
baseline characteristics might have been more favourable, but this
does not cause bias in the examined associations, as was
demonstrated in a previous study using data from the Morgen
cohort [45].
The possibility of residual confounding in the present study
cannot be ruled out, although we were able to control for
important factors as smoking, level of education, physical activity
and anthropometric indicators. When we repeated the main
analysis in never-smokers, estimates did not change notably. It is
possible that the baseline dietary measurement became increas-
ingly irrelevant to the development of cancers arising later after
baseline because of altered dietary habits. However, when we
performed an analysis by different follow-up periods, associations
for overall cancer were comparable for all follow-up periods.
In conclusion, in this population-based prospective cohort
study, a healthy diet defined by WHO guidelines was not
associated with overall cancer risk in men or women. The
components of the HDI may be too broad to detect an association
with cancer. Future studies investigating diet and cancer risk
should take into account other lifestyle components besides a
healthy diet.
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